Amylin (AMLN) Reports Q2 Adj-Loss of $0.36, Misses by 1c

July 21, 2009 4:07 PM EDT Send to a Friend

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) reports Q2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Amylin (AMLN) Reports Q2 Adj-Loss of $0.36, Misses by 1c

Member Login

Free News Feed